Ambitious scheme in Ireland to create 4,500 pharma research jobs, reportedly backed by Saudi government

24 September 2010

An ambitious plan is afoot to create 4,500 pharmaceutical research jobs in Ireland’s Co Kerr, with talks in progress with the government of Saudi Arabian government about funding the entire cost of the 4.7 billion-euro ($6.13 billion) project, the Irish Times reported yesterday. The country has recently seen a spate of job cuts in the pharmaceutical sector, as a result of cost-cutting moves by leading multinationals (The Pharma Letter September 14).

Taoiseach (Prime Minister) Brian Cowen has lent his support to the plan to create the large place of employment in Ireland and the biggest pharmaceutical research centre in the world on an industrial park in Tralee. Mr Cowen said the proposed Global Pharmaceutical Centre of Excellence could rely on the “supportive engagement” of the State enterprise agencies to help bring the project to fruition.

The center, which already employs 65 people, said it was finalizing plans for a planning application to Kerry County Council for a 1.2 million sq ft facility in the Kerry Technology Park in Tralee. It plans to open in February 2013, subject to planning and other permissions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical